USE OF 13-HODE AS A REGULATOR OF VASCULAR BIOCOMPATIBILITY AND AN INHIBITOR OF CELL HYPERPLASIA 13-HODE

摘要

This invention relates to the regulation of vascular endothelium biocompatibility and to the inhibition of vessel wall cell and other types of cell hyperplasia following vessel wall dysfunction and/or injury More particularly, the invention relates to the dietetic and pharmaceutical preparations of 13-hydroxyoctadeca-9Z, 11E-dienoic acid (13-HODE) and its use in reducing or inhibiting vessel wall hyperplasia and restoring vessel wall biocompatibility.